APRI Score Calculation and Clinical Significance in Hepatitis B
Formula and Calculation
- The APRI score is calculated using the formula: (AST/upper limit of normal for AST) × 100/platelet count (×10^9/L), as recommended by the American Association for the Study of Liver Diseases 1
- The formula consists of two main components: AST value divided by the upper limit of normal (ULN) for AST, and platelet count in 10^9/L, with a calculation of (AST/ULN for AST) × 100/platelet count 1, 2
Clinical Significance and Cutoff Values
- For significant fibrosis (≥F2), a low cutoff of APRI >0.5 is recommended, with a sensitivity of 72.9% and specificity of 64.7%, as suggested by the European Association for the Study of the Liver 3, 4
- For cirrhosis (F4), a low cutoff of APRI >1.0 is recommended, with a sensitivity of 59.4% and specificity of 73.9%, in line with WHO guidelines 4, 6
- The World Health Organization recommends using APRI >0.5 to identify most adults with significant fibrosis and APRI >1.0 to identify most adults with cirrhosis 6
Practical Application and Limitations
- APRI is recommended as a preferred non-invasive test due to its low cost, wide availability, and straightforward interpretation, as stated by the American Gastroenterological Association 3, 7
- In a population with 25% prevalence of significant fibrosis, using APRI >0.5 would result in 26.2% false positives but only 6.8% false negatives, prioritizing identifying patients who need treatment 3, 7, 8
- APRI performance may be influenced by acute hepatitis, conditions affecting AST levels or platelet counts, hemolysis, or Gilbert syndrome, as noted by the European Association for the Study of the Liver 1, 2